Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Sex/gender differences in cognitive trajectories vary as a function of race/ethnicity.

Avila JF, Vonk JMJ, Verney SP, Witkiewitz K, Arce Rentería M, Schupf N, Mayeux R, Manly JJ.

Alzheimers Dement. 2019 Sep 9. pii: S1552-5260(19)30110-4. doi: 10.1016/j.jalz.2019.04.006. [Epub ahead of print]

PMID:
31606366
2.

Recovery from addiction: Behavioral economics and value-based decision making.

Field M, Heather N, Murphy JG, Stafford T, Tucker JA, Witkiewitz K.

Psychol Addict Behav. 2019 Oct 10. doi: 10.1037/adb0000518. [Epub ahead of print]

PMID:
31599604
3.

Advances in the science and treatment of alcohol use disorder.

Witkiewitz K, Litten RZ, Leggio L.

Sci Adv. 2019 Sep 25;5(9):eaax4043. doi: 10.1126/sciadv.aax4043. eCollection 2019 Sep. Review.

4.

Patterns of Cocaine Use During Treatment: Associations With Baseline Characteristics and Follow-Up Functioning.

Roos CR, Nich C, Mun CJ, Mendonca J, Babuscio TA, Witkiewitz K, Carroll KM, Kiluk BD.

J Stud Alcohol Drugs. 2019 Jul;80(4):431-440.

PMID:
31495380
5.

Measurement invariance of neuropsychological measures of cognitive aging across race/ethnicity by sex/gender groups.

Avila JF, Rentería MA, Witkiewitz K, Verney SP, Vonk JMJ, Manly JJ.

Neuropsychology. 2019 Aug 29. doi: 10.1037/neu0000584. [Epub ahead of print]

PMID:
31464473
6.

Proactive inhibition deficits with normal perfusion after pediatric mild traumatic brain injury.

Mayer AR, Stephenson DD, Wertz CJ, Dodd AB, Shaff NA, Ling JM, Park G, Oglesbee SJ, Wasserott BC, Meier TB, Witkiewitz K, Campbell RA, Yeo RA, Phillips JP, Quinn DK, Pottenger A.

Hum Brain Mapp. 2019 Aug 28. doi: 10.1002/hbm.24778. [Epub ahead of print]

PMID:
31456319
7.

Temporal precedence of self-regulation over depression and alcohol problems: Support for a model of self-regulatory failure.

Acuff SF, Soltis KE, Dennhardt AA, Borsari B, Martens MP, Witkiewitz K, Murphy JG.

Psychol Addict Behav. 2019 Aug 26. doi: 10.1037/adb0000505. [Epub ahead of print]

PMID:
31448930
8.

Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response.

Witkiewitz K, Roos CR, Mann K, Kranzler HR.

Alcohol Clin Exp Res. 2019 Aug 22. doi: 10.1111/acer.14183. [Epub ahead of print]

PMID:
31436886
9.

Trait self-control predicts drinking patterns during treatment for alcohol use disorder and recovery up to three years following treatment.

Stein E, Witkiewitz K.

Addict Behav. 2019 Dec;99:106083. doi: 10.1016/j.addbeh.2019.106083. Epub 2019 Aug 8.

PMID:
31430618
10.

Response to Dr. Mark Litt's Commentary.

Anton RF, Witkiewitz K, Falk D, Litten R, Hasin D, Mann K, O'Malley S; Alcohol Clinical Trials Initiative (ACTIVE) Group.

Alcohol Clin Exp Res. 2019 Oct;43(10):2255-2256. doi: 10.1111/acer.14160. Epub 2019 Aug 26. No abstract available.

PMID:
31381170
11.

Demographic differences in perceived social norms of drug and alcohol use among Hispanic/Latinx and non-Hispanic White college students.

Edwards KA, Witkiewitz K, Vowles KE.

Addict Behav. 2019 Nov;98:106060. doi: 10.1016/j.addbeh.2019.106060. Epub 2019 Jul 24.

PMID:
31376659
12.

An open trial of rolling admission mindfulness-based relapse prevention (Rolling MBRP): feasibility, acceptability, dose-response relations, and mechanisms.

Roos C, Kirouac M, Stein E, Wilson A, Bowen S, Witkiewitz K.

Mindfulness (N Y). 2019 Jun;10(6):1062-1073. doi: 10.1007/s12671-018-1054-5. Epub 2018 Nov 12.

PMID:
31354877
13.

Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead.

Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, Del Felice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G, McDonald WM, Montemitro C, Nakamura-Palacios EM, Nasehi M, Noël X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, Salmeron BJ, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan TF, van Dongen JDM, Van Waes V, Venkatasubramanian G, Verdejo-García A, Verveer I, Welsh JW, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast MR, Zawertailo L, Zhang X, Cha YH, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA.

Neurosci Biobehav Rev. 2019 Sep;104:118-140. doi: 10.1016/j.neubiorev.2019.06.007. Epub 2019 Jul 2. Review.

PMID:
31271802
14.

Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population.

Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk DE, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS; Alcohol Clinical Trials (ACTIVE) Workgroup.

Drug Alcohol Depend. 2019 Aug 1;201:16-22. doi: 10.1016/j.drugalcdep.2019.03.020. Epub 2019 May 29.

PMID:
31174140
15.

Alcohol use disorder relapse factors: A systematic review.

Sliedrecht W, de Waart R, Witkiewitz K, Roozen HG.

Psychiatry Res. 2019 Aug;278:97-115. doi: 10.1016/j.psychres.2019.05.038. Epub 2019 May 25. Review.

PMID:
31174033
16.

Prevalence of Mental Health Problems and Willingness to Participate in a Mindfulness Treatment: An Examination among Veterans Injured in Combat.

Bravo AJ, Witkiewitz K, Kelley ML, Redman JC.

Mindfulness (N Y). 2019 May;10(5):953-963. doi: 10.1007/s12671-018-1047-4. Epub 2018 Nov 10.

PMID:
31131067
17.

A randomized clinical trial evaluating the efficacy of a brief alcohol intervention supplemented with a substance-free activity session or relaxation training.

Murphy JG, Dennhardt AA, Martens MP, Borsari B, Witkiewitz K, Meshesha LZ.

J Consult Clin Psychol. 2019 Jul;87(7):657-669. doi: 10.1037/ccp0000412. Epub 2019 May 9.

PMID:
31070386
18.

Alcohol use disorder and motives for prescription opioid misuse: A latent class analysis.

Votaw VR, McHugh RK, Witkiewitz K.

Subst Use Misuse. 2019;54(9):1558-1568. doi: 10.1080/10826084.2019.1594904. Epub 2019 May 7.

PMID:
31062626
19.

Sensitivity Analysis of the No-Omitted Confounder Assumption in Latent Growth Curve Mediation Models.

Tofighi D, Hsiao YY, Kruger ES, MacKinnon DP, Van Horn ML, Witkiewitz KA.

Struct Equ Modeling. 2019;26(1):94-109. doi: 10.1080/10705511.2018.1506925. Epub 2018 Sep 11.

PMID:
31057318
20.

Mindfulness-Based Relapse Prevention and Transcranial Direct Current Stimulation to Reduce Heavy Drinking: A Double-Blind Sham-Controlled Randomized Trial.

Witkiewitz K, Stein ER, Votaw VR, Wilson AD, Roos CR, Gallegos SJ, Clark VP, Claus ED.

Alcohol Clin Exp Res. 2019 Jun;43(6):1296-1307. doi: 10.1111/acer.14053. Epub 2019 May 9.

PMID:
30977904
21.

Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial.

Witkiewitz K, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF.

Alcohol Clin Exp Res. 2019 May;43(5):979-987. doi: 10.1111/acer.14018. Epub 2019 Apr 5.

22.

The (Lack of) Replication of Self-Reported Mindfulness as a Mechanism of Change in Mindfulness-Based Relapse Prevention for Substance Use Disorders.

Hsiao YY, Tofighi D, Kruger ES, Lee Van Horn M, MacKinnon DP, Witkiewitz K.

Mindfulness (N Y). 2019 Apr;10(4):724-736. doi: 10.1007/s12671-018-1023-z. Epub 2018 Sep 5.

PMID:
30931014
23.

Consumption outcomes in clinical trials of alcohol use disorder treatment: Consideration of standard drink misestimation.

Kirouac M PhD, Kruger E DPT, Wilson AD MS, Hallgren KA PhD, Witkiewitz K PhD.

Am J Drug Alcohol Abuse. 2019;45(5):451-459. doi: 10.1080/00952990.2019.1584202. Epub 2019 Mar 14.

24.

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.

Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J; Alcohol Clinical Trials Initiative (ACTIVE) Workgroup.

JAMA Psychiatry. 2019 Apr 1;76(4):374-381. doi: 10.1001/jamapsychiatry.2018.3079.

PMID:
30865232
25.

Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population.

Knox J, Scodes J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Anton R, Hasin DS; Alcohol Clinical Trials (ACTIVE) Workgroup.

Drug Alcohol Depend. 2019 Apr 1;197:228-235. doi: 10.1016/j.drugalcdep.2019.01.009. Epub 2019 Feb 14.

PMID:
30852375
26.

Non-invasive brain stimulation in substance use disorders: implications for dissemination to clinical settings.

Stein ER, Gibson BC, Votaw VR, Wilson AD, Clark VP, Witkiewitz K.

Curr Opin Psychol. 2018 Dec 19;30:6-10. doi: 10.1016/j.copsyc.2018.12.009. [Epub ahead of print] Review.

PMID:
30684906
27.

Predictive value of non-consumption outcome measures in alcohol use disorder treatment.

Kirouac M, Witkiewitz K.

Addiction. 2019 Jun;114(6):1086-1092. doi: 10.1111/add.14553. Epub 2019 Feb 6.

PMID:
30650471
28.

Opioid and sedative misuse among veterans wounded in combat.

Kelley ML, Bravo AJ, Votaw VR, Stein E, Redman JC, Witkiewitz K.

Addict Behav. 2019 May;92:168-172. doi: 10.1016/j.addbeh.2018.12.007. Epub 2018 Dec 10.

PMID:
30640149
29.

Assessing Time-Varying Causal Effect Moderation in Mobile Health.

Boruvka A, Almirall D, Witkiewitz K, Murphy SA.

J Am Stat Assoc. 2018;113(523):1112-1121. doi: 10.1080/01621459.2017.1305274. Epub 2017 Mar 29.

30.

Alcohol, tobacco, and marijuana expectancies as predictors of substance use initiation in adolescence: A longitudinal examination.

Montes KS, Witkiewitz K, Pearson MR, Leventhal AM.

Psychol Addict Behav. 2019 Feb;33(1):26-34. doi: 10.1037/adb0000422. Epub 2018 Nov 8.

PMID:
30407027
31.

Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.

Witkiewitz K, Kranzler HR, Hallgren KA, O'Malley SS, Falk DE, Litten RZ, Hasin DS, Mann KF, Anton RF.

Alcohol Clin Exp Res. 2018 Dec;42(12):2453-2465. doi: 10.1111/acer.13897. Epub 2018 Nov 5.

PMID:
30395350
32.

Double standards and gold standards in the evaluation of how a person feels and functions in substance use disorder pharmacotherapy trials.

Witkiewitz K.

Addiction. 2019 Jan;114(1):17-18. doi: 10.1111/add.14421. Epub 2018 Sep 11. No abstract available.

PMID:
30207010
33.

Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.

Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS; Alcohol Clinical Trials (ACTIVE) Workgroup.

Alcohol Clin Exp Res. 2018 Nov;42(11):2256-2265. doi: 10.1111/acer.13884. Epub 2018 Oct 3.

PMID:
30204248
34.

Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment.

Witkiewitz K, Kirouac M, Roos CR, Wilson AD, Hallgren KA, Bravo AJ, Montes KS, Maisto SA.

Psychol Addict Behav. 2018 Sep;32(6):639-646. doi: 10.1037/adb0000381. Epub 2018 Aug 30.

35.

Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders.

Votaw VR, Witkiewitz K, Valeri L, Bogunovic O, McHugh RK.

Addict Behav. 2019 Jan;88:48-55. doi: 10.1016/j.addbeh.2018.08.010. Epub 2018 Aug 14.

PMID:
30142484
36.

Mindfulness-based training with transcranial direct current stimulation modulates neuronal resource allocation in working memory: A randomized pilot study with a nonequivalent control group.

Hunter MA, Lieberman G, Coffman BA, Trumbo MC, Armenta ML, Robinson CSH, Bezdek MA, O'Sickey AJ, Jones AP, Romero V, Elkin-Frankston S, Gaurino S, Eusebi L, Schumacher EH, Witkiewitz K, Clark VP.

Heliyon. 2018 Jul 11;4(7):e00685. doi: 10.1016/j.heliyon.2018.e00685. eCollection 2018 Jul.

37.

Latent Profile Analysis of Alcohol Consumption and Sexual Attitudes Among College Women: Associations With Sexual Victimization Risk.

Yeater EA, Witkiewitz K, López G, Ross RS, Vitek K, Bryan A.

Violence Against Women. 2018 Sep;24(11):1279-1298. doi: 10.1177/1077801218787926.

PMID:
30078372
38.

Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?

Witkiewitz K, Wilson AD, Pearson MR, Montes KS, Kirouac M, Roos CR, Hallgren KA, Maisto SA.

Addiction. 2019 Jan;114(1):69-80. doi: 10.1111/add.14403. Epub 2018 Aug 24.

PMID:
30063267
39.

Response to Letter to Editor (Precision medicine in alcohol dependence: evidence of efficacy and initial support for comparative effectiveness).

Mann K, Roos CR, Witkiewitz K.

Neuropsychopharmacology. 2018 Aug;43(9):1801-1802. doi: 10.1038/s41386-018-0113-x. Epub 2018 Jun 12. No abstract available.

40.

Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence.

Witkiewitz K, Votaw VR, Vowles KE, Kranzler HR.

Alcohol Clin Exp Res. 2018 Jul;42(7):1249-1259. doi: 10.1111/acer.13772. Epub 2018 Jun 9.

41.

Alcohol and Opioid Use in Chronic Pain: A Cross-Sectional Examination of Differences in Functioning Based on Misuse Status.

Vowles KE, Witkiewitz K, Pielech M, Edwards KA, McEntee ML, Bailey RW, Bolling L, Sullivan MD.

J Pain. 2018 Oct;19(10):1181-1188. doi: 10.1016/j.jpain.2018.04.013. Epub 2018 Jun 4.

PMID:
29758355
42.

Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder.

Maisto SA, Hallgren KA, Roos CR, Witkiewitz K.

Drug Alcohol Depend. 2018 Jun 1;187:319-326. doi: 10.1016/j.drugalcdep.2018.03.011. Epub 2018 Apr 16.

43.

Corrigendum to "Mindfulness-based relapse prevention for substance craving" [Addictive Behaviors 38 (2013) 1563-1571].

Witkiewitz K, Bowen S, Douglas H, Hsu SH.

Addict Behav. 2018 Jul;82:202. doi: 10.1016/j.addbeh.2017.11.013. Epub 2018 Mar 22. No abstract available.

PMID:
29573890
45.

Advancing Analytic Approaches to Address Key Questions in Mechanisms of Behavior Change Research.

Hallgren KA, Wilson AD, Witkiewitz K.

J Stud Alcohol Drugs. 2018 Mar;79(2):182-189.

46.

Race/ethnicity and racial group composition moderate the effectiveness of mindfulness-based relapse prevention for substance use disorder.

Greenfield BL, Roos C, Hagler KJ, Stein E, Bowen S, Witkiewitz KA.

Addict Behav. 2018 Jun;81:96-103. doi: 10.1016/j.addbeh.2018.02.010. Epub 2018 Feb 7.

47.

When Traits Match States: Examining the Associations between Self-Report Trait and State Mindfulness following a State Mindfulness Induction.

Bravo AJ, Pearson MR, Wilson AD, Witkiewitz K.

Mindfulness (N Y). 2018 Feb;9(1):199-211. doi: 10.1007/s12671-017-0763-5. Epub 2017 Jul 13.

48.
49.

Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.

Witkiewitz K, Vowles KE.

Alcohol Clin Exp Res. 2018 Mar;42(3):478-488. doi: 10.1111/acer.13594. Epub 2018 Feb 6. Review.

50.

Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.

Mann K, Roos CR, Hoffmann S, Nakovics H, Leménager T, Heinz A, Witkiewitz K.

Neuropsychopharmacology. 2018 Mar;43(4):891-899. doi: 10.1038/npp.2017.282. Epub 2017 Nov 20.

Supplemental Content

Loading ...
Support Center